Literature DB >> 1164470

Photodynamic destruction of human bladder carcinoma.

J F Kelly, M E Snell, M C Berenbaum.   

Abstract

Eleven human bladder carcinomata of different degrees of differentiation were implanted in mice immunosuppressed by thymectomy, anti-thymocyte serum and x-rays. Seven carcinomata grew well and one poorly and 3 produced mainly fibrous nodules in the mice. Normal human bladder tissues were grown from 4 other patients. The administration of a haematoporphyrin derivative (HpD), followed 24 h later by exposure to white light, caused marked destruction of tumours but little or none of normal bladder tissues. HpD or light alone caused no damage to tumours or normal tissues. It is suggested that photodynamic therapy may be applicable in the treatment of superficial transitional cell carcinoma of the bladder.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1164470      PMCID: PMC2009375          DOI: 10.1038/bjc.1975.30

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  FURTHER EVALUATION OF THE USE OF HEMATOPORPHYRIN DERIVATIVE AS A NEW AID FOR THE ENDOSCOPIC DETECTION OF MALIGNANT DISEASE.

Authors:  R L LIPSON; E J BALDES; A M OLSEN
Journal:  Dis Chest       Date:  1964-12

2.  Photodynamic therapy of malignant tumours.

Authors:  I Diamond; S G Granelli; A F McDonagh; S Nielsen; C B Wilson; R Jaenicke
Journal:  Lancet       Date:  1972-12-02       Impact factor: 79.321

3.  Hematoporphyrin-derivative-fluorescence test colposcopy and colpophotography in the diagnosis of atypical metaplasia, dysplasia, and carcinoma in situ of the cervix uteri.

Authors:  G A Kyriazis; H Balin; R L Lipson
Journal:  Am J Obstet Gynecol       Date:  1973-10-01       Impact factor: 8.661

4.  Activated dyes as antitumor agents.

Authors:  T J Dougherty
Journal:  J Natl Cancer Inst       Date:  1974-04       Impact factor: 13.506

5.  Hematoporphyrin-derivative fluorescence in malignant neoplasms.

Authors:  H B Gregorie; E O Horger; J L Ward; J F Green; T Richards; H C Robertson; T B Stevenson
Journal:  Ann Surg       Date:  1968-06       Impact factor: 12.969

6.  The in vivo localization of porphyrins.

Authors:  D S Barker; R W Henderson; E Storey
Journal:  Br J Exp Pathol       Date:  1970-12

7.  Hematoporphyrin fluorescence: an aid in diagnosis of malignant neoplasms.

Authors:  J R Leonard; W L Beck
Journal:  Laryngoscope       Date:  1971-03       Impact factor: 3.325

8.  Use of hematoporphyrin derivative in detection and management of cervical cancer.

Authors:  M J Gray; R Lipson; J V Maeck; L Parker; D Romeyn
Journal:  Am J Obstet Gynecol       Date:  1967-11-15       Impact factor: 8.661

9.  The growth of human tumours in immunosuppressed mice and their response to chemotherapy.

Authors:  M C Berenbaum; C E Sheard; J R Reittie; R V Bundick
Journal:  Br J Cancer       Date:  1974-07       Impact factor: 7.640

  9 in total
  24 in total

1.  Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.

Authors:  Reema Railkar; L Spencer Krane; Q Quentin Li; Thomas Sanford; Mohammad Rashid Siddiqui; Diana Haines; Srinivas Vourganti; Sam J Brancato; Peter L Choyke; Hisataka Kobayashi; Piyush K Agarwal
Journal:  Mol Cancer Ther       Date:  2017-06-15       Impact factor: 6.261

2. 

Authors:  C S Betz; A Leunig
Journal:  HNO       Date:  2004-02       Impact factor: 1.284

3.  Advanced smart-photosensitizers for more effective cancer treatment.

Authors:  Wooram Park; Soojeong Cho; Jieun Han; Heejun Shin; Kun Na; Byeongdu Lee; Dong-Hyun Kim
Journal:  Biomater Sci       Date:  2017-12-19       Impact factor: 6.843

4.  Haematoporphyrin diacetate: a probe to distinguish malignant from normal tissue by selective fluorescence.

Authors:  R W Henderson; G S Christie; P S Clezy; J Lineham
Journal:  Br J Exp Pathol       Date:  1980-08

5.  Observations in studies of quantitative kinetics of tritium labelled hematoporphyrin derivatives (HpDI and HpDII) in the normal and neoplastic rat brain model.

Authors:  F M Little; C J Gomer; S Hyman; M L Apuzzo
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

Review 6.  Focal therapy in prostate cancer: modalities, findings and future considerations.

Authors:  Uri Lindner; John Trachtenberg; Nathan Lawrentschuk
Journal:  Nat Rev Urol       Date:  2010-09-14       Impact factor: 14.432

7.  Photodynamic therapy of experimental colonic tumours with 5-aminolevulinic-acid-induced endogenous porphyrins.

Authors:  K Orth; K König; F Genze; A Rück
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Hematoporphyrin derivative and anthracyclines mutually inhibit cellular uptake and toxicity.

Authors:  R M Böhmer; K Hoffmann; G Morstyn
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

9.  The direct determination of porphyrin carboxylic acids. High-pressure liquid chromatography with solvent systems containing phase-transfer agents.

Authors:  R Bonnett; A A Charalambides; K Jones; I A Magnus; R J Ridge
Journal:  Biochem J       Date:  1978-08-01       Impact factor: 3.857

10.  Ultrastructural changes in lymphoma cells treated with hematoporphyrin and light.

Authors:  A Coppola; E Viggiani; L Salzarulo; G Rasile
Journal:  Am J Pathol       Date:  1980-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.